Corrigendum to "Respiratory protection for healthcare workers treating Ebola virus disease (EVD): Are facemasks sufficient to meet occupational health and safety obligations?" [Int. J. Nurs. Stud. 50 (11) (2014) 1421-1426], DOI: 10.1016/j.ijnurstu.2014.09.002;Respiratory protection for healthcare workers treating ebola virus disease (EVD): Are facemasks sufficient to meet occupational health and safety obligations?

International Journal of Nursing Studies

Volumn 51, Issue 11, 2014, Pages 1421-1426

  MacIntyre, C Raina ^a   Chughtai, Abrar Ahmad ^a   Seale, Holly ^a   Richards, Guy A ^b,c   Davidson, Patricia M ^d,e  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

Author keywords

Ebola virus; Ebola virus disease; Facemasks; Healthcare workers; Respirators

Indexed keywords

DISEASE TRANSMISSION; GAS MASK; HEALTH CARE PERSONNEL; HEMORRHAGIC FEVER, EBOLA; HUMAN; OCCUPATIONAL HEALTH; PRACTICE GUIDELINE; PREVENTION AND CONTROL; TRANSMISSION; UTILIZATION;

HEALTH PERSONNEL; HEMORRHAGIC FEVER, EBOLA; HUMANS; INFECTIOUS DISEASE TRANSMISSION, PATIENT-TO-PROFESSIONAL; OCCUPATIONAL HEALTH; PRACTICE GUIDELINES AS TOPIC; RESPIRATORY PROTECTIVE DEVICES;

EID: 84908130714     PISSN: 00207489     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijnurstu.2014.10.011     Document Type: Erratum

References (49)

1. Alimonti J., Leung A., Jones S., Gren J., Qiu X., Fernando L., Balcewich B., Wong G., Stroher U., Grolla A., Strong J., Kobinger G. Evaluation of transmission risks associated with in vivo replication of several high containment pathogens in a biosafety level 4 laboratory. Sci. Rep. 2014, 4:5824.
2. Baize S., Pannetier D., Oestereich L., Rieger T., Koivogui L., Magassouba N., Soropogui B., Sow M.S., Keita S., De Clerck H., Tiffany A., Dominguez G., Loua M., Traore A., Kolie M., Malano E.R., Heleze E., Bocquin A., Mely S., Raoul H., Caro V., Cadar D., Gabriel M., Pahlmann M., Tappe D., Schmidt-Chanasit J., Impouma B., Diallo A.K., Formenty P., Van Herp M., Gunther S. Emergence of Zaire Ebola virus disease in Guinea - preliminary report. N. Engl. J. Med. 2014, (Epub ahead of print). http://www.nejm.org/doi/full/10.1056/NEJMoa1404505.
3. Barker J., Vipond I., Bloomfield S. Effects of cleaning and disinfection in reducing the spread of Norovirus contamination via environmental surfaces. J. Hosp. Infect. 2004, 58:42-49.
4. Bischoff W.E., Swett K., Leng I., Peters T.R. Exposure to influenza virus aerosols during routine patient care. J. Infect. Dis. 2013, 207:1037-1046.
5. Centers for Disease Control and Prevention (CDC). Infection Prevention and Control Recommendations for Hospitalized Patients with Known or Suspected Ebola Hemorrhagic Fever in U.S. Hospitals. Available at: (accessed 08.08.14.). http://www.cdc.gov/vhf/ebola/hcp/infection-prevention-and-control-recommendations.html.
6. Centers for Disease Control and Prevention (CDC). Recognizing the Biosafety Levels. Available at: (accessed 18.08.14.). http://www.cdc.gov/training/quicklearns/biosafety/.
7. Centers for Disease Control and Prevention (CDC) Fact Sheet: Basic Information about SARS 2004, Available at: http://www.cdc.gov/sars/about/fs-SARS.html (accessed 19.08.14.).
8. Centers for Disease Control and Prevention and World Health Organization Infection Control for Viral Haemorrhagic Fevers in the African Health Care Setting 1998, 1-198. Centers for Disease Control and Prevention, Atlanta.
9. Chughtai A.A., Seale H., MacIntyre C.R. Availability, consistency and evidence-base of policies and guidelines on the use of mask and respirator to protect hospital health care workers: a global analysis. BMC Res. Notes 2013, 6:216.
10. Dalgard D.W., Hardy R.J., Pearson S.L., Pucak G.J., Quander R.V., Zack P.M., Peters C.J., Jahrling P.B. Combined simian hemorrhagic fever and Ebola virus infection in cynomolgus monkeys. Lab. Anim. Sci. 1992, 42:152-157.
11. Department of Health, South Africa National Guidelines for Recognition and Management of Viral Haemorrhagic Fevers (Draft Guidelines) 2014, Available at: http://www.caa.co.za/Documents/Avmed/National%20Guidelines%20for%20Viral%20Haemorrhagic%20Fevers.pdf (accessed 30.08.14.).
12. Department of Health and Aging Australia Guidelines for Certification of a Physical Containment Level 4 Facility - Version 2.1 2007, Available at: http://www.ogtr.gov.au/internet/ogtr/publishing.nsf/content/certifications-1 (accessed 30.08.14.).
13. Jaax N., Jahrling P., Geisbert T., Geisbert J., Steele K., McKee K., Nagley D., Johnson E., Jaax G., Peters C. Transmission of Ebola virus (Zaire strain) to uninfected control monkeys in a biocontainment laboratory. Lancet 1995, 346:1669-1671.
14. Jackson C., Lowton K., Griffiths P. Infection prevention as "a show": a qualitative study of nurses' infection prevention behaviours. Int. J. Nurs. Stud. 2014, 51:400-408.
15. Jacobs J.L., Ohde S., Takahashi O., Tokuda Y., Omata F., Fukui T. Use of surgical face masks to reduce the incidence of the common cold among health care workers in Japan: a randomized controlled trial. Am. J. Infect. Control 2009, 37:417-419.
16. Johnson E., Jaax N., White J., Jahrling P. Lethal experimental infections of rhesus monkeys by aerosolized Ebola virus. Int. J. Exp. Pathol. 1995, 76:227-236.
17. Klompas M., Diekema D.J., Fishman N.O., Yokoe D.S. Ebola fever: reconciling Ebola planning with Ebola risk in US hospitals. Ann. Intern. Med. 2014, 10.7326/M14-M1918.
18. Kobinger G.P., Leung A., Neufeld J., Richardson J.S., Falzarano D., Smith G., Tierney K., Patel A., Weingartl H.M. Replication, pathogenicity, shedding, and transmission of Zaire Ebola virus in pigs. J. Infect. Dis. 2011, 204:200-208.
19. Leroy E.M., Kumulungui B., Pourrut X., Rouquet P., Hassanin A., Yaba P., Delicat A., Paweska J.T., Gonzalez J.P., Swanepoel R. Fruit bats as reservoirs of Ebola virus. Nature 2005, 438:575-576.
20. Loeb M., Dafoe N., Mahony J., John M., Sarabia A., Glavin V., Webby R., Smieja M., Earn D.J., Chong S., Webb A., Walter S.D. Surgical mask vs N95 respirator for preventing influenza among health care workers: a randomized trial. JAMA 2009, 302:1865-1871.
21. MacIntyre C.R., Wang Q., Cauchemez S., Seale H., Dwyer D.E., Yang P., Shi W., Gao Z., Pang X., Zhang Y., Wang X., Duan W., Rahman B., Ferguson N. A cluster randomized clinical trial comparing fit-tested and non-fit-tested N95 respirators to medical masks to prevent respiratory virus infection in health care workers. Influenza Other Respir. Viruses 2011, 5:170-179.
22. MacIntyre C.R., Wang Q., Seale H., Yang P., Shi W., Gao Z., Rahman B., Zhang Y., Wang X., Newall A.T., Heywood A., Dwyer D.E. A randomized clinical trial of three options for N95 respirators and medical masks in health workers. Am. J. Respir. Crit. Care Med. 2013, 187:960-966.
23. MacIntyre C.R., Seale H., Yang P., Zhang Y., Shi W., Almatroudi A., Moa A., Wang X., Li X., Pang X., Wang Q. Quantifying the risk of respiratory infection in healthcare workers performing high-risk procedures. Epidemiol. Infect. 2014, 142:1802-1808.
24. MacIntyre C.R., Wang Q., Rahman B., Seale H., Ridda I., Gao Z., Yang P., Shi W., Pang X., Zhang Y. Efficacy of face masks and respirators in preventing upper respiratory tract bacterial colonization and co-infection in hospital healthcare workers. Prev. Med. 2014, 62:1-7. 10.1016/j.ypmed.2014.01.015.
25. Marks P., Vipond I., Regan F., Wedgwood K., Fey R., Caul E. A school outbreak of Norwalk-like virus: evidence for airborne transmission. Epidemiol. Infect. 2003, 131:727-736.
26. Martin-Moreno J.M., Llinás G., Hernández J.M., Rodin G., Sharpe M., Walker J., Hansen C.H., Martin P., Symeonides S., Gourley C. Is respiratory protection appropriate in the Ebola response?. Lancet 2014, 384(9946):856.
27. McKinney K.R., Gong Y.Y., Lewis T.G. Environmental transmission of SARS at Amoy Gardens. J. Environ. Health 2006, 68:26-30. quiz 51-22.
28. Murray M., Grant J., Bryce E., Chilton P., Forrester L. Facial protective equipment, personnel, and pandemics: impact of the pandemic (H1N1) 2009 virus on personnel and use of facial protective equipment. Infect. Control Hosp. Epidemiol. 2010, 31:1011-1016.
29. Okware S.I., Omaswa F.G., Zaramba S., Opio A., Lutwama J.J., Kamugisha J., Rwaguma E.B., Kagwa P., Lamunu M. An outbreak of Ebola in Uganda. Trop. Med. Int. Health 2002, 7:1068-1075.
30. Public Health Agency of Canada Interim Biosafety Guidelines for Laboratories Handling Specimens from Patients Under Investigation for Ebola Virus Disease 2014, Available at: http://www.phac-aspc.gc.ca/id-mi/vhf-fvh/ebola-biosafety-biosecurite-eng.php (accessed 22.08.14.).
31. Public Health Agency of Canada Interim Guidance - Ebola Virus Disease: Infection Prevention and Control Measures for Borders, Healthcare Settings and Self-monitoring at Home 2014, Available at: http://www.phac-aspc.gc.ca/id-mi/vhf-fvh/ebola-ipc-pci-eng.php#tbl-3 (accessed 27.08.14.).
32. Richards G.A., Murphy S., Jobson R., Mer M., Zinman C., Taylor R., Swanepoel R., Duse A., Sharp G., De La Rey I.C. Unexpected Ebola virus in a tertiary setting: clinical and epidemiologic aspects. Crit. Care Med. 2000, 28:240-244.
33. Roels T.H., Bloom A.S., Buffington J., Muhungu G.L., Mac Kenzie W.R., Khan A.S., Ndambi R., Noah D.L., Rolka H.R., Peters C.J., Ksiazek T.G. Ebola hemorrhagic fever, Kikwit, Democratic Republic of the Congo, 1995: risk factors for patients without a reported exposure. J. Infect. Dis. 1999, 179(Suppl. 1):S92-S97.
34. Roy C.J., Milton D.K. Airborne transmission of communicable infection-the elusive pathway. N. Engl. J. Med. 2004, 22(350 (17)):1710-1712.
35. Siegel J.D., Rhinehart E., Jackson M., Chiarello L. 2007 Guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am. J. Infect. Control 2007, 35:S65-S164.
36. Sterk E. Filovirus Haemorrhagic Fever Guideline. Médecins Sans Frontières 2008, Available at: http://www.medbox.org/ebola-toolbox/filovirus-haemorrhagic-fever-guideline/preview (accessed 30.08.14.).
37. Superior Health Council, Belgium Practical Recommendations to the Attention of Healthcare Professionals and Health Authorities Regarding the Identification of and Care Delivered to Suspected or Confirmed Carriers of Highly Contagious Viruses (of the Ebola or Marburg type) in the Context of an Epidemic Outbreak in West Africa 2014, Available at: www.shea-online.org/Portals/0/PDFs/Belgian-guidelines-ebola.pdf (accessed 30.08.14.).
38. Tellier R. Aerosol transmission of influenza A virus: a review of new studies. J. R. Soc. Interface 2009, 6(6):S783-S790.
39. The Department of Health, Australia Ebola virus Disease (EVD) Outbreaks in West Africa. Important Information for Clinicians in Secondary or Tertiary Care 2014, Available at: www.health.gov.au/internet/main/.nsf/../ebola-clinicians-20140811.pdf (accessed 30.08.14.).
40. The Department of Health, UK Management of Hazard Group 4 Viral Haemorrhagic Fevers and Similar Human Infectious Diseases of High Consequence. Advisory Committee on Dangerous Pathogens 2014, Available at: www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1194947382005 (accessed 30.08.14.).
41. Thomson P. Ebola & Marburg Outbreak Control Guidance Manual. Version 2.0. Médecins Sans Frontières (MSF) 2007, Available at: http://www.medbox.org/ebola-toolbox/ebola-marburg-outbreak-control-guidance-manual/preview?q= (accessed 30.08.14.).
42. Weingartl H.M., Embury-Hyatt C., Nfon C., Leung A., Smith G., Kobinger G. Transmission of Ebola virus from pigs to non-human primates. Sci. Rep. 2012, 2:811.
43. World Health Organization (WHO) Ebola and Marburg Virus Disease Epidemics: Preparedness, Alert, Control, and Evaluation 2014, Available at: http://www.who.int/csr/disease/ebola/manual_EVD/en/ (accessed 28.08.14.).
44. World Health Organization (WHO) Ebola Virus Disease - Democratic Republic of Congo 2014, Available at: http://www.who.int/csr/don/2014_08_27_ebola/en/ (accessed 30.08.14.).
45. World Health Organization (WHO) Unprecedented Number of Medical Staff Infected with Ebola 2014, Available at: http://www.who.int/mediacentre/news/ebola/25-august-2014/en/ (accessed 28.08.14.).
46. World Health Organization (WHO). Ebola Virus Disease. Available at: (accessed 14.08.14.). http://www.who.int/csr/disease/ebola/en/.
47. World Health Organization (WHO). Ebola Virus Disease Update - West Africa. Available at: (accessed 22.08.14.). http://www.who.int/csr/don/2014_08_22_ebola/en/.
48. World Health Organization (WHO) Infection Prevention and Control Guidance for Care of Patients with Suspected or Confirmed Filovirus Haemorrhagic Fever in Health-care Settings, With Focus on Ebola 2014, Available at: http://www.who.int/csr/bioriskreduction/filovirus_infection_control/en/ (accessed 02.09.14.).
49. Yu I.T., Li Y., Wong T.W., Tam W., Chan A.T., Lee J.H., Leung D.Y., Ho T. Evidence of airborne transmission of the severe acute respiratory syndrome virus. N. Engl. J. Med. 2004, 350:1731-1739.